• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Celtaxsys - Articles and news items

Celtaxsys gains US clearance for Phase 2 trial of acebilustat in patients with cystic fibrosis

Industry news / 7 July 2015 /

Celtaxsys has gained clearance from the US FDA to begin a Phase 2 clinical trial of acebilustat in adult patients with cystic fibrosis (CF) in the US…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +